It's that time of year when flu vaccines are becoming available in Australia. You may have received an email from your GP ...

The journal 'Nature' publishes data from Wales showing a 20% reduction in risk with vaccination. They support the hypothesis ...

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older.

A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...

The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...

Analysis of a Welsh program offering live-attenuated shingles vaccines to people born after a certain date showed a 20 percent relative drop in dementia risk.

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

A large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The ...

The Oxford study based on the health records of 200,000 people from the US, found a 17 per cent reduction in dementia ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

Recommendations on the strain composition of influenza virus vaccines for the 2025-2026 US season have been issued by FDA.

The current study assessed dementia risk in people who had received the older vaccine, which used a live-attenuated form of the virus. Shingrix is a recombinant zoster vaccine. David Cutler ...